Total Debt
$10.8M
Net Debt
-$466M
Rapport Therapeutics, Inc. Common Stock currently has $10.8M in total debt. Net debt is -$466M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
RAPP • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.01 | 0.48 | -0.47Net Cash | 0.50 | 2.2% |
| 2025-12-31 | 0.01 | 0.49 | -0.48Net Cash | 0.51 | 2.2% |
| 2025-09-30 | 0.01 | 0.51 | -0.50Net Cash | 0.54 | 2.2% |
| 2025-06-30 | 0.01 | 0.26 | -0.25Net Cash | 0.29 | 4.2% |
| 2025-03-31 | 0.01 | 0.29 | -0.28Net Cash | 0.30 | 2.6% |
| 2024-12-31 | 0.00 | 0.31 | -0.30Net Cash | 0.31 | 0.5% |
| 2024-09-30 | 0.00 | 0.32 | -0.32Net Cash | 0.33 | 0.5% |
| 2024-06-30 | 0.00 | 0.34 | -0.33Net Cash | 0.35 | 0.5% |
| 2024-03-31 | 0.00 | 0.19 | -0.19Net Cash | 0.21 | 1.0% |
| 2023-12-31 | 0.00 | 0.15 | -0.15Net Cash | 0.16 | 1.4% |